Related Experiment Video
Updated: Aug 5, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines
Shirley V Wang1, Abdurrahman Abdurrob1, Julia Spoendlin1
1Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital; Department of Medicine, Harvard Medical School, Boston, MA, USA.
Insights
Investigating childhood immunization safety, this study developed a method to assess risks of vaccines given on the same day. Adjusting for age, it found little evidence of increased seizure risk from DTaP and MMR vaccines administered together.
Area of Science:
- Immunization Safety
- Vaccine Epidemiology
- Pediatric Public Health
Background:
- Childhood immunization schedules often involve multiple vaccines per visit.
- Concerns exist regarding the safety of administering vaccines concomitantly (on the same day).
- Observational studies face methodological challenges in assessing concomitant vaccine safety.
Purpose of the Study:
- To address methodological challenges in observational studies of concomitant vaccine safety.
- To develop a process for identifying specific vaccines responsible for adverse events when administered together.
- To adjust for confounding factors related to vaccine combinations and risk factors.
Main Methods:
- Utilized a self-controlled design for observational vaccine safety studies.
- Proposed a method to distinguish individual vaccine contributions to adverse events.
- Re-examined seizure risk post-measles-mumps-rubella (MMR) vaccination, assessing other vaccine effects.
- Adjusted for time-invariant effect modifiers like age at vaccination.
Main Results:
- Initial analyses suggested DTaP had independent and potentiating effects on seizure risk.
- After adjusting for age and vaccine combinations, minimal evidence supported increased seizure risk with same-day DTaP and MMR administration (IRR 1.2 [0.9-1.6]).
Conclusions:
- Adjusting for time-invariant effect modifiers, such as age, is crucial in self-controlled designs for concomitant vaccine safety.
- Age at vaccination is structurally related to vaccination patterns in recommended schedules.
- The findings highlight the importance of robust statistical methods in vaccine safety research.
Purpose:
The need to develop methods for studying the safety of childhood immunization schedules has been recognized by the Institute of Medicine and Department of Health and Human Services. The recommended childhood immunization schedule includes multiple vaccines in a visit. A key concern is safety of concomitant (same day) versus separate day vaccination. This paper addresses a methodological challenge for observational studies using a self-controlled design to investigate the safety of concomitant vaccination.
Methods:
We propose a process for distinguishing which of several concomitantly administered vaccines is responsible for increased risk of an adverse event while adjusting for confounding due to relationships between effect modifying risk factors and concomitant vaccine combinations. We illustrate the approach by re-examining the known increase in risk of seizure 7 to 10 days after measles-mumps-rubella (MMR) vaccination and evaluating potential independent or modifying effects of other vaccines.
Results:
Initial analyses suggested that DTaP had both an independent and potentiating effect on seizure. After accounting for the relationship between age at vaccination and vaccine combination, there was little evidence for increased risk of seizure with same day administration of DTaP and MMR; incidence rate ratio, 95% confidence interval 1.2 (0.9-1.6), P value = θ.226.
Conclusion:
We have shown that when using a self-controlled design to investigate safety of concomitant vaccination, it can be critically important to adjust for time-invariant effect modifying risk factors, such as age at time of vaccination, which are structurally related to vaccination patterns due to recommended immunization schedules.
More Related Videos
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Related Concept Videos
Cross-reactivity
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Vaccines
Smallpox